Recent Updates
Recently added Catalysts
MXCT Positive Sentiment Score: 65/100

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

Thursday, April 10, 2025 1 min read
Key Takeaway: MaxCyte, Inc. announced it will release its financial results for the first quarter of 2025 after market close on May 7, 2025. The company is known for its focus on cell engineering technologies for therapeutics. Following the release, a conference call will be hosted by management to discuss the results and stakeholders are encouraged to register in advance to listen. A webcast of the event will be available on MaxCyte's investor website.

Market Sentiment Analysis

POSITIVE FACTORS

  • MaxCyte is actively engaging with investors by providing timely financial updates.
  • The anticipated earnings conference call indicates transparency and commitment to stakeholder communication.
  • The release of financial results on May 7 suggests the company is on schedule with its reporting.

Full Press Release Details

ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the first quarter 2025 after the U.S. market close on Wednesday, May 7th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.
Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Events” section of the MaxCyte website at https://investors.maxcyte.com/.
jvines@spectrumscience.com
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley
maxcyte@icrhealthcare.com

Frequently Asked Questions

When will MaxCyte release its Q1 2025 financial results?

MaxCyte will release its Q1 2025 financial results on May 7th, 2025.

What time is the earnings conference call scheduled?

The earnings conference call is set for 4:30 p.m. Eastern Time.

How can investors listen to the conference call?

Investors must register online to listen to the conference call.

Where can archived webcasts of the event be found?

Archived webcasts will be available in the 'Events' section on MaxCyte's website.

Tags: MXCT Viatris Investor Conferences Healthcare MaxCyte cell therapeutics financial results conference call
Last updated: Apr 10, 2025